Prophylactic treatment with Bacteroides uniformis and Bifidobacterium bifidum counteracts hepatic NK cell immune tolerance in nonalcoholic steatohepatitis induced by high fat diet

References

• Stefan N, Schick F, Birkenfeld AL, Haring HU, White MF. The role of hepatokines in NAFLD. Cell Metab. 2023;35(2):236–20. doi:10.1016/j.cmet.2023.01.006.
   PubMed Web of Science ®Google Scholar
• Shashni B, Tajika Y, Ikeda Y, Nishikawa Y, Nagasaki Y. Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis. Biomaterials. 2023;295:122047. doi:10.1016/j.biomaterials.2023.122047.
   PubMed Web of Science ®Google Scholar
• Pinter M, Pinato DJ, Ramadori P, Heikenwalder M. NASH and hepatocellular carcinoma: immunology and immunotherapy. Clin Cancer Res. 2023;29(3):513–520. doi:10.1158/1078-0432.CCR-21-1258.
   PubMed Web of Science ®Google Scholar
• Klieser E, Mayr C, Kiesslich T, Wissniowski T, Fazio PD, Neureiter D, Ocker M. The crosstalk of miRNA and oxidative stress in the liver: from physiology to pathology and clinical implications. Int J Mol Sci. 2019;20(21):5266. doi:10.3390/ijms20215266.
   PubMed Web of Science ®Google Scholar
• Martinez-Chantar ML, Delgado TC, Beraza N. Revisiting the role of natural killer cells in non-alcoholic fatty liver disease. Front Immunol. 2021;12:640869. doi:10.3389/fimmu.2021.640869.
   PubMed Web of Science ®Google Scholar
• Tosello-Trampont AC, Krueger P, Narayanan S, Landes SG, Leitinger N, Hahn YS. NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice. Hepatology. 2016;63(3):799–812. doi:10.1002/hep.28389.
   PubMed Web of Science ®Google Scholar
• Michelet X, Dyck L, Hogan A, Loftus RM, Duquette D, Wei K, Beyaz S, Tavakkoli A, Foley C, Donnelly R. et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat Immunol. 2018;19(12):1330–40. doi:10.1038/s41590-018-0251-7.
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang X, Liu W, Zhou Y, Wei W, Liu D, Wong CC, Sung JJY, Yu J. Activated natural killer cell promotes nonalcoholic steatohepatitis through mediating JAK/STAT pathway. Cell Mol Gastroenterol Hepatol. 2022;13(1):257–274. doi:10.1016/j.jcmgh.2021.08.019.
   PubMed Web of Science ®Google Scholar
• Tumino N, Nava Lauson CB, Tiberti S, Besi F, Martini S, Fiore PF, Scodamaglia F, Mingari MC, Moretta L, Manzo T. et al. The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity. Int J Cancer. 2023;152(8):1698–706. doi:10.1002/ijc.34389.
   PubMed Web of Science ®Google Scholar
• Sivori S, Pende D, Quatrini L, Pietra G, Della Chiesa M, Vacca P, Tumino N, Moretta F, Mingari MC, Locatelli F. et al. NK cells and ILCs in tumor immunotherapy. Mol Aspects Med. 2021;80:80. doi:10.1016/j.mam.2020.100870.
   Web of Science ®Google Scholar
• Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, Rautela J, Straube J, Waddell N, Blake SJ. et al. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat Immunol. 2017;18(9):1004–15. doi:10.1038/ni.3800.
   PubMed Web of Science ®Google Scholar
• Yin H, Miao Z, Wang L, Su B, Liu C, Jin Y, Wu B, Han H, Yuan X. Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota. Aging (Albany NY). 2022;14:1941–58. doi:10.18632/aging.203914.
   PubMedGoogle Scholar
• Tian P, Yang W, Guo X, Wang T, Tan S, Sun R, Xiao R, Wang Y, Jiao D, Xu Y. et al. Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis. Nat Commun. 2023;14(1):1710. doi:10.1038/s41467-023-37419-7.
   PubMed Web of Science ®Google Scholar
• Jung YJ, Kim HS, Jaygal G, Cho HR, Lee KB, Song IB, Kim JH, Kwak MS, Han KH, Bae MJ. et al. Postbiotics enhance NK cell activation in stress-induced mice through gut microbiome regulation. J Microbiol Biotechnol. 2022;32(5):612–20. doi:10.4014/jmb.2111.11027.
   PubMed Web of Science ®Google Scholar
• Gui Q, Wang A, Zhao X, Huang S, Tan Z, Xiao C, Yang Y. Effects of probiotic supplementation on natural killer cell function in healthy elderly individuals: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2020;74(12):1630–7. doi:10.1038/s41430-020-0670-z.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Cuevas J, Lucano-Landeros S, López-Cifuentes D, Santos A, Armendariz-Borunda J. Epidemiologic, genetic, pathogenic, metabolic, epigenetic aspects involved in NASH-HCC: Current therapeutic strategies. Cancers. 2022;15(1). doi:10.3390/cancers15010023.
   PubMed Web of Science ®Google Scholar
• Castera L, Laouenan C, Vallet-Pichard A, Vidal-Trecan T, Manchon P, Paradis V, Roulot D, Gault N, Boitard C, Terris B. et al. High prevalence of NASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT, using a low threshold. Diab Care. 2023;46(7):1354–1362. doi:10.2337/dc22-2048.
   PubMed Web of Science ®Google Scholar
• Callegari IOM, Rocha GZ, Oliveira AG. Physical exercise, health, and disease treatment: the role of macrophages. Front Physiol. 2023;14:1061353. doi:10.3389/fphys.2023.1061353.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Cheng L, Liu L, Li X. NK cells are never alone: crosstalk and communication in tumour microenvironments. Mol Cancer. 2023;22(1):34. doi:10.1186/s12943-023-01737-7.
   PubMed Web of Science ®Google Scholar
• Shen H, Cai X, Liu J, Yan G, Ye Y, Dong R, Wu J, Li L, Shen Q, Ma Y. et al. Case report: the clinical utility of metagenomic next-generation sequencing in mucormycosis diagnosis caused by fatal lichtheimia ramosa infection in pediatric neuroblastoma. Front Pediatr. 2023;11:1130775. doi:10.3389/fped.2023.1130775.
   PubMed Web of Science ®Google Scholar
• Jiang X, Melum E. The role of natural killer cells in nonalcoholic steatohepatitis: an ongoing debate. Cell Mol Gastroenterol Hepatol. 2022;13(1):348–349. doi:10.1016/j.jcmgh.2021.10.006.
   PubMed Web of Science ®Google Scholar
• Contreras D, Gonzalez-Rocha A, Clark P, Barquera S, Denova-Gutierrez E. Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: systematic review and meta-analysis. Ann Hepatol. 2023;28(1):100873. doi:10.1016/j.aohep.2022.100873.
   PubMed Web of Science ®Google Scholar
• Tada T, Saibara T, Ono M, Takahashi H, Eguchi Y, Hyogo H, Kawanaka M, Kumada T, Toyoda H, Yasuda S. et al. Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver disease. Eur J Gastroen Hepat. 2021;33(11):1451–1458. doi:10.1097/MEG.0000000000002176.
   PubMed Web of Science ®Google Scholar
• Ogawa K, Kobayashi T, Furukawa JI, Hanamatsu H, Nakamura A, Suzuki K, Kawagishi N, Ohara M, Umemura M, Nakai M. et al. Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis. Sci Rep. 2020;10(1):321. doi:10.1038/s41598-019-56947-1.
   PubMed Web of Science ®Google Scholar
• Turkseven S, Turato C, Villano G, Ruvoletto M, Guido M, Bolognesi M, Pontisso P, Di Pascoli M. Low-dose acetylsalicylic acid and mitochondria-targeted antioxidant mitoquinone attenuate non-alcoholic steatohepatitis in mice. Antioxid (Basel). 2023;12(4):971. doi:10.3390/antiox12040971.
   PubMedGoogle Scholar
• Aziz N, Bonavida B. Activation of natural killer cells by probiotics. For Immunopathol Dis Therap. 2016;7(1–2):41–55. doi:10.1615/ForumImmunDisTher.2016017095.
   PubMedGoogle Scholar
• Yang X, Guo Y, Chen C, Shao B, Zhao L, Zhou Q, Liu J, Wang G, Yuan W, Sun Z. Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment. Immunology. 2021;164(3):476–93. doi:10.1111/imm.13397.
   PubMed Web of Science ®Google Scholar
• Yu Q, Newsome RC, Beveridge M, Hernandez MC, Gharaibeh RZ, Jobin C, Thomas RM. Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells. Gut Microbes. 2022;14(1):2112881. doi:10.1080/19490976.2022.2112881.
   PubMed Web of Science ®Google Scholar
• Thomas LM. Current perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptors. Immunotargets Ther. 2015;4:45–53. doi:10.2147/ITT.S61498.
   PubMedGoogle Scholar
• Liu XH, Zhou JT, Yan CX, Cheng C, Fan JN, Xu J, Zheng Q, Bai Q, Li Z, Li S. et al. Single-cell RNA sequencing reveals a novel inhibitory effect of ApoA4 on NAFL mediated by liver-specific subsets of myeloid cells. Front Immunol. 2022;13:1038401. doi:10.3389/fimmu.2022.1038401.
   PubMed Web of Science ®Google Scholar
• Zhu J, Lin Q, Zheng H, Rao Y, Ji T. The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma. Front Oncol. 2022;12:897042. doi:10.3389/fonc.2022.897042.
   PubMed Web of Science ®Google Scholar
• Tabellini G, Baronio M, Patrizi O, Benevenuto A, Gazzurelli L, Plebani A, Parolini S, Lougaris V. The RAC2-PI3K axis regulates human NK cell maturation and function. Cl Immunol. 2019;208:208. doi:10.1016/j.clim.2019.108257.
   Web of Science ®Google Scholar
• Moncayo G, Lin D, Mccarthy MT, Watson AA, O’callaghan CA. MICA expression is regulated by cell adhesion and contact in a FAK/Src-dependent manner. Front Immunol. 2016;7:687. doi:10.3389/fimmu.2016.00687.
   PubMed Web of Science ®Google Scholar
• Su Y, Huang H, Luo T, Zheng Y, Fan J, Ren H, Tang M, Niu Z, Wang C, Wang Y. et al. Cell-in-cell structure mediates in-cell killing suppressed by CD44. Cell Discov. 2022;8(1):35. doi:10.1038/s41421-022-00387-1.
   PubMed Web of Science ®Google Scholar
• Kang HS, Liao G, Degraff LM, Gerrish K, Bortner CD, Garantziotis S, Jetten AM, Brennan L. CD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistance. PLoS One. 2013;8(3):e58417. doi:10.1371/journal.pone.0058417.
   PubMed Web of Science ®Google Scholar
• Kodama K, Toda K, Morinaga S, Yamada S, Butte AJ. Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice. DIABETES. 2015;64(3):867–75. doi:10.2337/db14-0149.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zheng M, Ding Q, Liu M. CD93 correlates with immune infiltration and impacts patient immunotherapy efficacy: a pan-cancer analysis. Front Cell Dev Biol. 2022;10:817965. doi:10.3389/fcell.2022.817965.
   PubMed Web of Science ®Google Scholar
• Sun Y, Chen W, Torphy RJ, Yao S, Zhu G, Lin R, Lugano R, Miller EN, Fujiwara Y, Bian L. et al. Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy. Sci Transl Med. 2021;13(604). doi:10.1126/scitranslmed.abc8922.
   Web of Science ®Google Scholar
• Zhao CZ, Jiang W, Zhu YY, Wang CZ, Zhong WH, Wu G, Chen J, Zhu MN, Wu QL, Du XL. et al. Highland barley Monascus purpureus went extract ameliorates high-fat, high-fructose, high-cholesterol diet induced nonalcoholic fatty liver disease by regulating lipid metabolism in golden hamsters. J Ethnopharmacol. 2022;286:114922. doi:10.1016/j.jep.2021.114922.
   PubMed Web of Science ®Google Scholar
• Xie L, Chen T, Qi X, Li H, Xie J, Wang L, Xie J, Huang Z. Exopolysaccharides from Genistein-Stimulated Monascus purpureus Ameliorate Cyclophosphamide-Induced Intestinal Injury via PI3K/AKT-MAPKs/NF-kappaB Pathways and Regulation of Gut Microbiota. J Agric Food Chem. 2023;71(35):12986–13002. doi:10.1021/acs.jafc.3c03186.
   PubMed Web of Science ®Google Scholar
• He GQ, Xiao L, Pan Z, Wu JR, Liang DN, Guo X, Jiang MY, Gao J. Case report: A rare case of pulmonary mucormycosis caused by Lichtheimia ramosa in pediatric acute lymphoblastic leukemia and review of Lichtheimia infections in leukemia. Front Oncol. 2022;12:949910. doi:10.3389/fonc.2022.949910.
   PubMed Web of Science ®Google Scholar
• Dai X, Zhou X, Shao R, Zhao R, Yanamandra AK, Xing Z, Ding M, Wang J, Liu T, Zheng Q. et al. Bioactive constituents of verbena officinalis alleviate inflammation and enhance killing efficiency of natural killer cells. Int J Mol Sci. 2023;24(8):7144. doi:10.3390/ijms24087144.
   PubMed Web of Science ®Google Scholar
• Frasca D, Blomberg BB. Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology. 2016;17(1):7–19. doi:10.1007/s10522-015-9578-8.
   PubMed Web of Science ®Google Scholar
• Hur MH, Song W, Cheon D-H, Chang Y, Cho YY, Lee YB, Yu SJ, Kim YJ, Yoon J-H, Choi HJ. et al. Chemogenetic stimulation of the parasympathetic nervous system lowers hepatic lipid accumulation and inflammation in a nonalcoholic steatohepatitis mouse model. Life Sci. 2023;321:121533. doi:10.1016/j.lfs.2023.121533.
   PubMed Web of Science ®Google Scholar
• Nunez SY, Ziblat A, Secchiari F, Torres NI, Sierra JM, Raffo Iraolagoitia XL, Araya RE, Domaica CI, Fuertes MB, Zwirner NW. Human M2 macrophages limit NK cell effector functions through secretion of TGF-beta and engagement of CD85j. J Immunol. 2018;200(3):1008–1015. doi:10.4049/jimmunol.1700737.
   PubMed Web of Science ®Google Scholar
• Park MD, Reyes-Torres I, Leberichel J, Hamon P, Lamarche NM, Hegde S, Belabed M, Troncoso L, Grout JA, Magen A. et al. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Nat Immunol. 2023;24(5):792–801. doi:10.1038/s41590-023-01475-4.
   PubMedGoogle Scholar